Munich, Germany

Winfried Uftring

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Winfried Uftring: Innovator in Ophthalmic Lens Technology

Introduction

Winfried Uftring is a notable inventor based in Munich, Germany. He has made significant contributions to the field of ophthalmic lens technology. His innovative approach has led to the development of a unique apparatus designed for the heat treatment of ophthalmic lenses, particularly contact lenses.

Latest Patents

Winfried Uftring holds 1 patent for his invention titled "Apparatus for the heat treatment of ophthalmic lenses." This apparatus features an approximately cylindrical housing with an inlet and outlet opening. It includes a transport device that moves ophthalmic lenses located inside molds along an open transport path. This path is arranged in a spiral shape within the housing, and a heating device is positioned above and below the transport path to ensure effective heat treatment.

Career Highlights

Throughout his career, Uftring has been associated with Ciba-Geigy Corporation, a company known for its advancements in pharmaceuticals and healthcare products. His work has focused on improving the quality and efficiency of ophthalmic lens production.

Collaborations

Winfried Uftring has collaborated with notable colleagues such as Lothar Haase and Theo Bachmann. Their combined expertise has contributed to the success of various projects within the field of ophthalmic technology.

Conclusion

Winfried Uftring's innovative contributions to ophthalmic lens technology demonstrate his commitment to enhancing the industry. His patent for the heat treatment apparatus showcases his ability to address specific needs in lens production.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…